Position article and guidelines
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma
Prostate cancer is the most commonly diagnosed malignancy and second leading cause of cancer death among men in the United States. In recent years, several new agents, including cancer immunotherapies, have be...
Journal for ImmunoTherapy of Cancer 2016 4:92
Published on: 20 December 2016